Skip to content

Application of autologous bone graft in intramedullary nail fixation for intertrochanteric fracture: a prospective randomized controlled clinical trial

Application of autologous bone graft in intramedullary nail fixation for intertrochanteric fracture: a prospective randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044557
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-03-17
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intertrochanteric fracture

Interventions

Bone graft group:Autologous bone fragments were implanted into the posterior medial bone defect of the femoral calcar During PFNA surgery.

Sponsors

Affiliated Hospital of Chengde Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Femoral intertrochanteric fracture with AO classification A2; 2. Actue fracture within 2 weeks; 3. Aged 30-90 years; 4. Fully understand and voluntarily sign informed consent; Those who meet all the above conditions can join the study.

Exclusion criteria

Exclusion criteria: 1. Need open reduction during operation; 2. Need long nail for fixation; 3. Open fracture; 4. Patients with mental disorders or severe bone changes(Pathological fracture); 5. Patients with other organ injury or fracture need additional treatment such as operation; 6. Accompanied with neuromotor disfunction or lower limb muscle strength abnormality; 7. Patients with severe coagulation dysfunction; Those who meet one of the above conditions shall be excluded.

Design outcomes

Primary

MeasureTime frame
Fracture healing time;

Secondary

MeasureTime frame
Harris score;VAS;operation time;Amount of bleeding in operation;full weight-bearing after operation;

Countries

China

Contacts

Public ContactXinlong Zhang

Affiliated Hospital of Chengde Medical University

zhangxl125@qq.com+86 314-2279267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026